Markets
markets

Healthcare stocks sink after Trump admin proposes flat rates for Medicare insurers

Major health insurers and healthcare companies are under pressure in early trading on Tuesday after the Trump administration proposed roughly flat rates for Medicare insurers next year.

The Centers for Medicare and Medicaid Services announced after the bell on Monday that payments to the plan will increase by just 0.09% in 2027, less than the 4% to 6% analysts expected. CMS also plans to crack down on inaccurate overbilling by changing how “risk score,” which pays more for sicker patients, is calculated.

Private Medicare plans, or Medicare Advantage, is a core business for insurers including UnitedHealth, CVS Health, and Humana, which all fell double digits in premarket trading on Tuesday. Even insurers less dependent on Medicare specifically, like Elevance Health, Centene, and Molina Healthcare dropped more than 5%.

Among the healthcare giants, UnitedHealth is the biggest loser this morning, with its shares down 14% after its woes were compounded by a lackluster full-year forecast. The company expects a decline in yearly revenue for 2026 — which would be its first annual revenue decrease in more than three decades. The company has also been under investigation by the Department of Justice for its Medicare billing practices.

The announcement comes after a difficult year for insurers, particularly those that offer government-sponsored plans. Insurers are likely to lobby for higher payments before the rate is finalized in April. If it goes through unchanged, plans will likely slash coverage and raise premiums to protect margins, according to analysts at Deutsche Bank.

“The industry was in the earliest stages of a multi-year margin recovery cycle which will now be in question,” the analysts wrote in a Tuesday morning note.

Private Medicare plans, or Medicare Advantage, is a core business for insurers including UnitedHealth, CVS Health, and Humana, which all fell double digits in premarket trading on Tuesday. Even insurers less dependent on Medicare specifically, like Elevance Health, Centene, and Molina Healthcare dropped more than 5%.

Among the healthcare giants, UnitedHealth is the biggest loser this morning, with its shares down 14% after its woes were compounded by a lackluster full-year forecast. The company expects a decline in yearly revenue for 2026 — which would be its first annual revenue decrease in more than three decades. The company has also been under investigation by the Department of Justice for its Medicare billing practices.

The announcement comes after a difficult year for insurers, particularly those that offer government-sponsored plans. Insurers are likely to lobby for higher payments before the rate is finalized in April. If it goes through unchanged, plans will likely slash coverage and raise premiums to protect margins, according to analysts at Deutsche Bank.

“The industry was in the earliest stages of a multi-year margin recovery cycle which will now be in question,” the analysts wrote in a Tuesday morning note.

More Markets

See all Markets
markets

Eli Lilly receives its only sell rating from HSBC, which cites smaller market for weight-loss drugs

Eli Lilly slipped in early trading after analysts at HSBC gave the pharmaceutical darling at the center of the obesity drug boom a rare downgrade.

Analysts at the bank cut their rating to “reduce” from “hold.” They cut their price target to $850 from $1,070. The stock closed at $989 on Monday.

According to Bloomberg, this is the only sell rating on Lilly among the 38 analysts who cover the stock.

The company has rallied more than 20% in the past year as its obesity drug sales continue to rise, far outpacing its top rival, Novo Nordisk. But the space is getting increasingly crowded with new entrants as well as new products from Lilly and Novo, putting downward pricing pressure on their products.

HSBC: ".. We downgrade Lilly to Reduce (from Hold) as we cut our medium-term forecasts for the market .. We think Lilly shares are priced to perfection .. and think medium-term earnings trends are optimistic. .. the total addressablemarket (TAM) for obesity might be USD80-120bn (not >USD150bn)."

— Carl Quintanilla (@carlquintanilla.bsky.social) March 17, 2026 at 12:24 PM
markets

Nebius drops after announcing that it aims to raise $3.75 billion in a convertible loan offering

Nebius dropped as much as 7.5% in premarket trading on Tuesday, after the AI infrastructure company announced its intentions to sell $3.75 billion worth of convertible senior notes with maturities in 2031 and 2033.

The company will offer the debt in two tranches, the first batch worth $2 billion and due March 15, 2031, followed by $1.75 billion worth of notes due March 15, 2033. There’s also the potential for an additional $562.5 million of these notes to be issued via an over-allotment option.

The interest and initial conversion rate will be determined at the pricing of the offering, but regardless of the premium, a $3.75 billion offering would be pretty sizable for a company that closed yesterday’s trading session with a ~$33 billion market cap, and the market is quickly pricing in a decent chunk of equity dilution.

The offering is conspicuous in its timing, with Nebius soaring 15% yesterday on the back of a major infrastructure deal with Meta — worth up to $27 billion over five years.

The funds will likely be put to good use to deliver on some of these major projects. Per the company’s press release, the capital raised will be used to:

“...finance the continuing growth of its business, including expenditures related to the construction and build-out of its data centers, investments to develop its full-stack AI cloud, the expansion of its data center footprint and the procurement of key components (including GPUs), and for general corporate purposes.”

markets

Amazon introduces 1- and 3-hour delivery options in hundreds of new towns and cities

Harder, better, stronger, faster... Amazon, not content with completely altering our expectations for how quickly our goods should arrive, is rolling out one- and three-hour deliveries in new cities in the US as it continues to double down on ultrafast delivery.

Per the company’s press release, one-hour delivery is now available in “hundreds of cities and towns” in the US, and three-hour options are offered in “over 2,000 cities and towns,” both available seven days a week though their regular same-day shopping experience. More than 90,000 products, which are typically available in local supercenters, are currently eligible for delivery under the two plans, and Amazon expects to bring the new scheme to more areas in the coming months.

Delivery fees for Prime members are set at $9.99 for one-hour delivery and $4.99 for three hours, though this price range more than doubles to $19.99 and $14.99, respectively, for customers without a Prime membership.

Regarding the new delivery options, Udit Madan, Amazon’s senior vice president of worldwide operations, said, “We’re excited to say that two decades after Prime launched, we’re still innovating to make delivery even faster, while maintaining the same everyday low prices and vast selection Amazon is known for.”

Indeed, since it launched same-day delivery in 2015, Amazon has been experimenting with a number of ultrafast delivery options, including recently piloting a 30-minute delivery service in selected US cities, built on its network of fulfillment centers and on-demand workers. The e-commerce giant’s latest push also comes as competitors like Walmart have started to boost its delivery capacity, touting that it can deliver to 95% of American households in less than three hours.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.